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Abstract
Background: An organ such as the bladder consists of complex, interacting set of tissues and cells. Inflammation has
been implicated in every major disease of the bladder, including cancer, interstitial cystitis, and infection. However, scanty
is the information about individual detrusor and urothelium transcriptomes in response to inflammation. Here, we used
suppression subtractive hybridizations (SSH) to determine bladder tissue- and disease-specific genes and transcriptional
regulatory elements (TRE)s. Unique TREs and genes were assembled into putative networks.
Results: It was found that the control bladder mucosa presented regulatory elements driving genes such as myosin light
chain phosphatase and calponin 1 that influence the smooth muscle phenotype. In the control detrusor network the Pax3 TRE was significantly over-represented. During development, the Pax-3 transcription factor (TF) maintains progenitor
cells in an undifferentiated state whereas, during inflammation, Pax-3 was suppressed and genes involved in neuronal
development (synapsin I) were up-regulated. Therefore, during inflammation, an increased maturation of neural
progenitor cells in the muscle may underlie detrusor instability. NF-κB was specifically over-represented in the inflamed
mucosa regulatory network. When the inflamed detrusor was compared to control, two major pathways were found,
one encoding synapsin I, a neuron-specific phosphoprotein, and the other an important apoptotic protein, siva. In
response to LPS-induced inflammation, the liver X receptor was over-represented in both mucosa and detrusor
regulatory networks confirming a role for this nuclear receptor in LPS-induced gene expression.
Conclusion: A new approach for understanding bladder muscle-urothelium interaction was developed by assembling
SSH, real time PCR, and TRE analysis results into regulatory networks. Interestingly, some of the TREs and their
downstream transcripts originally involved in organogenesis and oncogenesis were also activated during inflammation.
The latter represents an additional link between inflammation and cancer. The regulatory networks represent key targets
for development of novel drugs targeting bladder diseases.
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Background
The lower urinary tract is subject to a number of functional disorders in which a cross-communication between
urothelium and detrusor muscle is a factor. Bladder overactivity has been attributed to detrusor muscle dysfunction, and several in vitro and in vivo methodologies have
been developed to better understand its pathophysiology
[1]. Although the detrusor muscle participates intensively
in the inflammatory response, practically every major disease of the urinary bladder, including cancer, interstitial
cystitis, and infection [2], involves the urothelium [3].
The urinary bladder develops as a result of indispensable
epithelial-mesenchymal interactions responsible for
directing urothelial differentiation and for normal
smooth muscle development [4,5]. However, in adulthood, the urinary bladder is a highly heterogeneous
organ, consisting of a large variety of cell types, and this
complexity presents challenges to the study of physiological and cellular processes in health and disease. This was
evident in studies determining gene regulation [6-11] and
target validation [12]. In the latter study, the expression of
protease-activating receptors (PAR) was differentially distributed between bladder mucosa, detrusor smooth muscle, and nerve elements. Moreover, during inflammation,
PAR expression was up-regulated in the mucosa contrasting with its down-regulation in the detrusor muscle [12].
These results suggested a possible differential distribution
of proteins between bladder mucosa and detrusor muscle
and indicated the need for reduction of the whole tissue
into specific layers.

The present work was undertaken to elucidate the transcriptional complexity of inflammation, as modeled in
the mouse urinary bladder. The first step towards the
study of individual layers was the separation of the
mucosa and submucosa layers away from the detrusor
smooth muscle and adventitia (See Additional file 1). We
went further to determine low abundant transcripts, using
suppression subtractive hybridization (SSH) and selected
ones were confirmed by real time PCR. Next, the SSHoriginated transcripts were annotated and analyzed for
significantly enriched transcriptional regulatory elements
(TRE) using PAINT [Promoter Analysis and Interaction
Network Toolset; [13]]. PAINT utilizes TRANSFAC database [14] containing eukaryotic cis-acting regulatory DNA
elements and trans-acting factors. The pattern search tool
MATCH in TRANSFAC suite is employed to identify the
TREs on cognate 5' upstream regulatory sequences [15].
Putative regulatory networks were assembled using
known interactions among genes and their coded proteins
as well as information about TREs that were significantly
over-represented in the genes comprising inflammatory
and control transcriptomes. Together, these results constitute the first demonstration of the transcriptional complexity underlying the different layers of the urinary
bladder and their contribution to the early phases of bladder inflammation.

Results
SSH. From each library, at least 50 clones were further
sequenced and annotated, for a total of 300 clones. The
present work reports only tissue-specific transcripts

Table 1: Primers for real time PCR

Gene

GenBank ID

Bcap31
Catenin
Cnn1
Dlk1
eiF-4E
Grn
Grp58
GSTM1
GSTO1
IFIT3
LAMP2
Mafb
Mpp1
Pls3
Prss11
Sirt1
Smoc2
SPRR2A
SYN1
TMPRSS2
Upk1a

NM_009922
BC043108
NM_009922
D16847
NM_010124
X62321
BC003285
NM_010358
NM_010362
BC003804
NM_010685
AF180338
U38196
NM_145629
NM_019564
AF214646
NM_022315
BC010818
NM_013680
AF199362
AF262335

5' primer sequence
AAAGAATATGACCGCCTGCTAGA
CCTCCCCCACCCACATCTA
AGTTGTTTGCTGCCAAGTCTGA
CTTTTTGTGGTGGAGTTTGCTCTAT
TGTGCTTGGCTGCTGAGAGA
CTACCTAAAGGGTGTCTGCTGTAGA
AAAACCAGAGAGGACAGAATGGATAA
TCTCCTTCCCGCTCCCTT
GGCAAGAGCCCTCAGCAA
TGTGGTGGATTCTTGGCAGTT
TGGCACTGGCTTAATGCTGTT
CCATCTTGAGAAGGTAGCAGCAA
AGATTGCCATCCTTGACATTGA
CACACCCAGGCTCAAAGGA
AGTCAACATTTGTCCCTTCCCTTA
CCTGCATAGATCTTCACCACAaat
CCACTATGGGATGAAGGTTATGA
ATAGCAACACTTCCATCCTCCTTT
GTTCTAAAGTCATCGTTCGGTTCTTAA
AATCACACCAGCCATGATCTGT
GGCAACTTCATCCCCATCAA

3' primer sequence
AAGCCTTTACTCCTCCTTCTTGACT
ACCCACACCCCACCGAgaa
GGTGGAAGGCAGTTTAATGGAGT
gCGTGGTAGCATGGCACACA
ACGGACAGACGGACGATGA
AGGAATCTTCTTTCGCAAACACTT
TGTATTTTCAAACAGTGCAGCTAAGAA
GAGAATGAAGGCTGTGTGGACTT
TGAGAAAGGAGCCAGTGAGAATACT
CTGCCTGTGCCCCAAAGT
GTGCTTTGGAGGTATCTCAATATGAA
AAAGTTGGGCTTGGTGGGTT
GTAGGTGCGATGAACACAATGAA
TTGTGATAAAGATTTCCAAACAAACAA
GGCTGCGAGGACCTTCCT
ACACTCTCCCCAGTAGAAGTACCATT
AGAAAGTGACAGCCAGCCATACA
TGAGGAGCCATCATAAGCACAT
TTCCCAGCTCTGTGATCATCAA
AATCAGCCACCAGATCCCATT
AGCAACCCTTGGTAAACAGGTAGT

localization
761–847
4957–5049
2081–2168
1859–1950
1446–1531
1630–1729
1627–1712
965–1047
826–912
1279–1366
3132–3218
3731–3840
1301–1388
2816–2902
1752–1837
3016–3108
2377–2465
379–471
3334–3424
1364–1473
580–652
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Table 2: Mouse bladder transcripts isolated by SSHs

Abbrev

Name

Accession

Library

QPCR

2310015N07
Actg1
Actg2
Actr3
Ambladder
Amcq
Aplp2
Bcap31
Calm2
Catenin
Cnn1
Col3a1
Cox7b
CoxI
Cpe
Cts e
Cts h
Cts l
Ddx3
DnaJ
Eif4ebp2
Elp3
Endomuc1
Fth1
Gpam/GPAT
Grn
Grp58
Gst a4
Gst m1
Gst o1
Gus
IFIT3
Ifrg15
Lamp2
Lrrfip2
Ly6d
Mafb
Mgs1-182e11
MLZE
Mpp1
My h11
My lc2b/MRLC2
My19
Pls3
Prdx1
Prnp
Prss11
RP23-452N23
RP23-70M6
RPCI23
RPs21
RPs7
SAC1
SC1
SCP-1
Sdfr1
Sepp1/SePP
Serpina3n
Sf 3b2

RIKEN cDNA 2310015N07 gene
actin, gamma 1, cytoplasmic
actin, gamma 2, smooth muscle, enteric
ARP3 actin-related protein 3 homolog (yeast)
adult male urinary bladder cDNA, RIKEN clone:9530014P05
adult male corpora quadrigemina cDNA, RIKEN clone:B230340L02
amyloid beta (A4) precursor-like protein 2 isoform 751
B-cell receptor-associated protein 31
calmodulin 2
similar to catenin src
calponin 1
collagen, type III, alpha 1, RIKEN 3200002K15
cytochrome c oxidase subunit VIIb
mitochondrial gene for subunit I of cytochrome c oxidase
carboxypeptidase E (Cpe),
cathepsin E (Ctse)
cathepsin H
cathepsin L
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3
Hsp40 homolog, subfamily A, member 2
eukaryotic translation initiation factor 4E binding protein 2
elongation protein 3 homolog, RIKEN clone:2610507P14
endomucin-1
ferritin heavy chain 1
glycerol-3-phosphate acyltransferase
epithelin 1 and 2 (granulin)
glucose regulated protein
glutathione S-transferase, alpha 4
glutathione S-transferase, mu 1
glutathione S-transferase omega 1
beta-glucuronidase
interferon-induced protein with tetratricopeptide repeats 3
interferon alpha responsive gene
lysosomal membrane glycoprotein 2
leucine rich repeat (in FLII) interacting protein 2
mRNA for THB / lymphocyte antigen 6 complex, locus D
transcription factor MAFB
clone mgs1-182e11 strain 129/SvJ
adult female vagina cDNA, RIKEN clone 9930109F21
palmytoylated protein p55
myosin heavy chain 11, smooth muscle
myosin light chain, regulatory B
myosin, light polypeptide 9, regulatory
similar to plastin 3 precursor (T-isoform)
peroxiredoxin 1
prion protein
protease, serine, 11 (Igf binding) HtrA1
clone RP23-452N23 on chromosome 4
chromosome 18 clone RP23-70M6
Strain C57BL6/J Chromosome 2, clone RP23-111A22
ribosomal protein S21 / RIKEN cDNA 2410030A14 gene
ribosomal protein S7
suppressor of actin mutations
extracellular matrix protein precursor
SCP-1 mRNA for stromal cell derived protein-1
stromal cell derived factor receptor 1
selenoprotein P, plasma,1 glycoprotein
serine (or cysteine) proteinase inhibitor (clade A, member 3N)
splicing factor 3b, subunit 2, clone MGC:61326 IMAGE:6812422

NM_025515
NM_009609
NM_009610
NM_023735
AK020558
AK080832
U15571
NM_012060
NM_007589
BC043108
NM_009922
AK019448
NM_025379
X57780
NM_013494
NM_007799
NM_007801
NM_009984
NM_010028
NM_019794
NM_010124
AK012072
BC003706
NM_010239
NM_008149
X62321
BC003285
NM_010357
NM_010358
NM_010362
NM_010368
BC003804
NM_022329
NM_010685
XM_284541
X63782
AF180338
AC096622
AK037079
U38196
XM_147228
NM_023402
XM_283793
NM_145629
NM_011034
NM_011170
NM_019564
AL928645
AC114820
AC078911
BC027563
NM_011300
AJ245720
U77330
D16847
NM_009145
NM_009155
NM_009252
BC049118

MIDI
MIC
MIDI
MIC
MC
MIC
MIDI
MIDI
MC
MIC
MC
MIDI
MIC
MIC
MIC
MIC
DC
MIC
MIDI
MIDI
DIC
MIDI
MIC
MIC
MIC
MC
MIC
MIDI
DC
DC
MIDI
MIC
DC
MIC
MIDI
MIDI
MIC
MIDI
MIDI
DIC
MIDI
MC
MIDI
MIC
MIDI
DC
MIC
MIC
MIC
MIDI
MIC
MIDI
MC
MC
MIC
DC
MIC
DC
MIDI

N
N
N
N
N
Y
N
Y
N
N
N
N
N
N
N
N
N
Y
Y
N
N
Y
N
N
Y
N
Y
N
Y
Y
N
Y
N
N
Y
N
N
Y
N
N
Y
Y
N
Y
N
Y
N
N
N
Y
N
Y
Y
N
Y
N
Y
Y
N
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Table 2: Mouse bladder transcripts isolated by SSHs (Continued)

Sf rs6
Sf sc35
Sirt1
Siva
Smoc2
Sparc
Sprr 2A
Syn1
Tcra-V13.1
Thsd6
TMPRSS2
Tnnt3
UDP-gluco
Upk1a
Upk1b
Wdr1
Zfp364

splicing factor, arginine/serine-rich 6
splicing factor SC35
Sir1 alpha protein
Cd27 binding proapoptotic protein
SPARC related modular calcium binding 2
secreted acidic cysteine rich glycoprotein
small proline-rich protein 2A
synapsin I or ribosomal protein S15a
T-cell receptor alpha/delta locus
thrombospondin, type I domain containing 6
transmembrane protease, serine 2
troponin T3, skeletal, fast
UDP-glucuronosyltransferase 1 family, member 2
uroplakin 1a
uroplakin 1b
WD repeat domain 1
zinc finger protein 364/Rab7

(mucosa vs detrusor) and treatment-specific transcripts
(saline vs LPS). 120 transcripts were considered to be
unique. These indicate that each of these 120 transcript
occurred in a specific subtraction. Transcripts that
appeared in more than one subtraction were not considered unique and therefore, not included. Selection of
clones ceased when a substantial number of additional
sequences [approximately 180] did not reveal any additional unique transcript. Next, 120 clones were sequenced
and analyzed for homology in the GenBank and EMBL
databases.
Seventy six cDNA fragments (Table 2) were further annotated using the Mouse Genome Information [16] according to Gene Ontology and presented in Table 3. Among
the 76 fragments selected for futher annotation, 21 fragments had homology with expressed sequence tags (ESTs)
and cDNA clones for which information about tissue specificity, biologycal or molecular function is not available.
Interestingly, one of these clones (ambladder; RIKEN
clone:9530014P05) was originally isolated from an adult
male bladder cDNA library [17].
SSH-selected transcripts
Table 3 summarizes the isolated transcripts that in general
are involved in: actin dynamics (wdr1); apoptosis (sirt1,
siva, and bcap31); calcium ion binding (pls3, sc1, scp-1,
sparc, and smoc2); cell adhesion (col3a1 and catenin); cell
cycle/ G-protein coupled receptor (cam2); cell growth
(prss11); cell motility (actr3); cytoskeleton organization
and biogenesis (actg1, actg2, and mylc2b);defense
response (ly6d); electron transport (cox7b, grp58, and
coxI); epithelial cell proliferation (grn); immune response
(ifit3); insulin processing (cpe); iron ion transport (fth1);
metabolism/ glutathione transferase activity (gsto1, gsta4,
and gstm1); negative regulation of translational initiation
(eif4ebp2); nuclear mRNA splicing (sfsc35 and sfrs6); phos-

NM_026499
AF077858
AF214646
NM_013929
NM_022315
NM_009242
BC010818
NM_013680
AE008684
NM_025629
NM_015775
NM_011620
BC019434
AF262335
NM_178924
NM_011715
NM_026406

MIC
MIDI
MIDI
DIC
MIC
MIDI
MC
DIC
MIC
DC
MIDI
MIDI
MIC
DC
DC
MIDI
MIDI

N
N
N
Y
N
N
Y
Y
N
Y
N
N
N
N
N
N
N

pholipid biosynthesis (gpam); positive regulation of transcription (mafb); post-embryonic development (sepp1);
protein biosynthesis (rps7 and rps21); protein folding
(dnaJ); protein ubiquitination (zfp364); proteolysis (ctse,
ctsh, ctsl, Aplp2, serpina3n, and tmprss2); regulation of cell
shape (sprr2A); regulation of muscle contraction (my19
and cnn1); response to oxidative stress (prdx1 and prnp);
synaptic transmission (syn1); and tRNA aminoacylation
(lamp2).
Target validation by quantitative real-time polymerase
chain reaction (QRT-PCR)
From the annotated transcripts (Table 2), twenty six were
selected for further analysis by QRT-PCR. The results are
summarized in Table 4. In tissues isolated from salinetreated mice the following transcripts were expressed preferentially in the detrusor muscle when compared to the
mucosa layer: ctsh, eif4ebp2, gstm1, gsto1, serpina3n, sprr2A,
upk1a, and upk1b. With the exception of serpina3n, all
detrusor-specific transcripts were also preferentially up
regulated in the inflamed detrusor. In contrast, calm2,
cnn1, and smoc2 were preferentially expressed in the bladder mucosa of control mice. With the exception of calm2,
all other mucosa-specific transcripts were up-regulated
during inflammation. Table 4 also segregates transcripts
that were represented in both layers of control mice and
that were up-regulated during the inflammatory process.
The latter include: bcap31, catenin, pls3, mafb, prss11,
mpp1, syn1, lamp2, and sepp1.
TREs
Figure 2 contains over-represented TREs and the downstream transcripts that were found primarily in the bladder mucosa when compared to detrusor muscle isolated
from control mice (MC). In contrast, figure 5 contains
over-represented TFs and transcripts that were found primarily in the control detrusor muscle (DC). TFs and
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Table 3: ANNOTATION (GENE ONTOLOGY) OF SSH-ISOLATED TRANSCRIPT FROM MOUSE URINARY BLADDER

Biological Process

Abbrev

Molecular Function

Cellular Component

Accession

actin dynamics
apoptosis
apoptosis
apoptosis
calcium ion binding
calcium ion binding
calcium ion binding
calcium ion binding
calcium ion binding
cell adhesion

Wdr1
Sirt1
Bcap31
Siva
SCP-1
Sparc
Smoc2
Pls3
SC1
Col3a1

actin cytoskeleton
chromatin silencing complex
Golgi membrane
cytoplasm
integral to membrane
basement membrane
extracellular space
unknown
extracellular space
collagen

NM_011715
AF214646
NM_012060
NM_013929
D16847
NM_009242
NM_022315
NM_145629
U77330
AK019448

cell adhesion
cell cycle/G-protein coupled receptor
cell growth (regulation)
cell motility
cytoskeleton organization and
biogenesis
cytoskeleton organization and
biogenesis
cytoskeleton organization and
biogenesis
defense response
electron transport
electron transport

Catenin
Calm2
Prss11
Actr3
Actg1

actin binding
NAD-dependent histone deacetylase
receptor binding
CD27 receptor binding
calcium ion binding
calcium ion binding
calcium ion binding
calcium ion binding
calcium ion binding
extracellular matrix structural
constituent
protein binding
protein binding
insulin-like growth factor binding
structural molecule
motor activity

cytoskeleton
plasma membrane
extracellular region
actin cytoskeleton
actin cytoskeleton

BC043108
NM_007589
NM_019564
NM_023735
NM_009609

Actg2

motor activity

actin cytoskeleton

NM_009610

My lc2b

unknown

cytoskeleton

NM_023402

Ly6d
Grp58
Cox7b

unknown
electron transporter
oxidoreductase activity

X63782
BC003285
NM_025379

electron transport

CoxI

epithelial cell proliferation
immune response
insulin processing
iron ion transport
metabolism
metabolism
metabolism
negative regulation of translational
initiation
nuclear mRNA splicing, via spliceosome
nuclear mRNA splicing, via spliceosome
nuclear mRNA splicing, via spliceosome
phospholipid biosynthesis
positive regulation of transcription
post-embryonic development
protein biosynthesis
protein biosynthesis
protein folding
protein ubiquitination
proteolysis and peptidolysis
proteolysis and peptidolysis
proteolysis and peptidolysis
proteolysis and peptidolysis
regulation of cell shape
regulation of muscle contraction
regulation of muscle contraction
response to oxidative stress
response to oxidative stress
synaptic transmission
tRNA aminoacylation
unknown
unknown
unknown

Grn
IFIT3
Cpe
Fth1
Gst a4
Gst m1
Gst o1
Eif4ebp2

ubiquinol-cytochrome-c reductase
activity
phospholipase A2
unknown
carboxypeptidase A and E activity
ferric iron binding
glutathione transferase
glutathione transferase
glutathione transferase
insulin receptor signaling pathway

plasma membrane
endoplasmic reticulum
mitochondrial electron transport
chain
mitochondrion
mitochondrion
unknown
extracellular space
unknown
unknown
unknown
cytoplasm
unknown

X62321
BC003804
NM_013494
NM_010239
NM_010357
NM_010358
NM_010362
NM_010124

Sf sc35
Sf 3b2
Sf rs6
Gpam
Mafb
Sepp1
RPs21
RPs7
DnaJ
Zfp364
Cts e
Cts h
Cts l
TMPRSS2
Sprr 2A
Cnn1
Myl19
Prdx1
Prnp
Syn1
Lamp2
RPCI23
Mgs1-182e11
RP23-70M6

DNA binding
unknown
pre-mRNA splicing factor
acyltransferase
DNA binding
selenium binding
structural constituent of ribosome
RNA binding
unfolded protein binding
ubiquitin-protein ligase activity
neutrophil collagenase activity
cysteine-type endopeptidase activity
cysteine-type endopeptidase activity
trypsin activity
constituent of cytoskeleton
calmodulin binding
calcium ion binding
antioxidant activity
copper ion binding
protein dimerization
tRNA ligase
unknown
unknown
unknown

spliceosome complex
nucleus
nucleus
mitochondrion
transcription factor complex
extracellular space
ribosome
ribosome
membrane
ubiquitin ligase complex
extracellular space
lysosome
lysosome
integral to membrane
cornified envelope
unknown
myosin
unknown
Golgi apparatus
synaptic vesicle membrane
platelet dense granule membrane
unknown
unknown
unknown

AF077858
BC049118
NM_026499
NM_008149
AF180338
NM_009155
BC027563
NM_011300
NM_019794
NM_026406
NM_007799
NM_007801
NM_009984
NM_015775
BC010818
NM_009922
XM_283793
NM_011034
NM_011170
NM_013680
NM_010685
AC078911
AC096622
AC114820

X57780
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Table 3: ANNOTATION (GENE ONTOLOGY) OF SSH-ISOLATED TRANSCRIPT FROM MOUSE URINARY BLADDER (Continued)

unknown
unknown
unknown
unknown
unknown
unknown
unknown
unknown
unknown
unknown
unknown
unknown
unknown
unknown
unknown
unknown
unknown
unknown
unknown
unknown

Tcra-V13.1
Upk1a
SAC1
Elp3
Ambladder
MLZE
Amcq
RP23452N23
Endomuc1
UDP-gluco
Sdfr1
Serpina3n
Ddx3
Gus
Tnnt3
Ifrg15
2310015N07
Thsd6
Upk1b
Aplp2

unknown
unknown
unknown

Mpp1
My h11
Lrrfip2

unknown
unknown
unknown
N-acetyltransferase activity
unknown
unknown
unknown
unknown

unknown
integral to membrane
integral to membrane
mitochondrion
unknown
unknown
unknown
unknown

AE008684
AF262335
AJ245720
AK012072
AK020558
AK037079
AK080832
AL928645

unknown
unknown
receptor activity
endopeptidase inhibitor
ATP-dependent helicase activity
unknown
unknown
unknown
unknown
unknown
unknown
serine-type endopeptidase inhibitor
activity
protein binding
unknown
unknown

integral to membrane
unknown
integral to membrane
extracellular space
intracellular
unknown
unknown
unknown
unknown
extracellular space
integral to membrane
integral to membrane

BC003706
BC019434
NM_009145
NM_009252
NM_010028
NM_010368
NM_011620
NM_022329
NM_025515
NM_025629
NM_178924
U15571

membrane
unknown
unknown

U38196
XM_147228
XM_284541

downstream transcripts specifically expressed in bladder
mucosa during inflammation were compared to control
mucosa (Figure 3) or to the inflamed detrusor (Figure 4).
In contrast, the response of detrusor muscle to inflammation was determined in comparison to detrusor control
(Figure 6) or inflamed mucosa (Figure 7). The results presented here demonstrate the concept that combining SSH
methodology with PAINT-guided transcriptional regulatory element analysis permitted the generation of testable
hypotheses regarding differences between mucosa and
detrusor regulatory networks in health and disease states.

Discussion
We used a highly effective method for differential gene
analysis, termed suppression subtractive hybridization
(SSH), which has been developed for the generation of
subtracted cDNA libraries. It is based primarily on suppression PCR and combines normalization and subtraction in a single procedure [18]. The normalization step
equalizes the abundance of cDNAs within the target population and the subtraction step excludes the common
sequences between the target and driver populations. In a
model system, the SSH technique enriched for rare
sequences over 1,000-fold in one round of subtractive
hybridization [18]. Unlike microarrays, which mainly
identify moderate to high abundant genes, SSH identifies
clones that are expressed at very low levels. It is possible
that some of the extremely low-level gene expression is
not biologically significant, as it might arise from 'random
transcription' [19]. Therefore, we confirmed the differen-

tial expression of twenty six SSH-selected transcripts by
QRT-PCR and the results were highly correlated. In addition, we introduced a redundancy factor by comparing the
data generated from the analysis of multiple SSH libraries
(MC, DC, MIC, MIDI, DID, and DIMI). Nevertheles, the
question of validation certainly is an important one, and
it is one we have considered. For one, we examined properties of the candidate genes that were independent of
expression, such as the presence of promoter sequences,
to increase the probability that mechanisms suggested by
the expression data were not simply statistical anomalies.
Moreover, the finding that mechanisms known to be
operant emerged from the analysis also increases confidence that novel ones are valid as well.
This study was carried out at a single time point. The 24
hour time point was chosen because it coincides with the
peak of acute inflammation [8,9]. This point characterizes
the acute inflammatory responses to LPS and in addition
to edema and vasodilation, the peak response of neutrophil infiltration occurred at 24 h in the mucosa and
submucosa as well as in the detrusor smooth muscle [8,9].
The rationale for a single time point was to keep the
number of variables within a reasonable limit. We understand that 24 h time point may not identify preceding or
proceeding events as we indicated previously [7-9]. Therefore, the results of regulatory network here presented
should be viewed as a snapshot of the inflammatory transcriptome at the point of maximal inflammatory
response. Nevertheless, genes identified as important at
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this time point can now be followed over time by other
techniques.
By using cDNA subtractions between mucosa and detrusor smooth muscle layers isolated from control and
inflamed bladders, several clones identified transcripts
that were further annotated. It has to be taken in consideration that the mucosal layer contains the urothelial
layer and the lamina propria which involves other cell
types (fibroblasts, myofibroblasts, etc.) in addition to
urothelial cells that may underlie the transcriptomes identified. In addition, during the inflammation, inflammatory cells are present in the detrusor as well as in the
mucosa and may contribute to the inflammatory bladder
transcriptome.
Some of the transcripts are RIKEN sequences and therefore, have no biological process attributed. Interestingly,
some of these transcripts with unknown function, such as
ambladder, have been reported in the adult male urinary
bladder by others using SSH [17]. However, the present
work indicates that the same transcript was isolated from
female urinary bladder as well.
Central to elucidation of hypothetical cis-regulatory networks is the identification and classification of naturally
occurring transcription factor-binding sites in subtracted
libraries. The combination of SSH-derived transcripts
with PAINT-guided query of the TRANSFAC database permitted the generation of regulatory networks containing
upstream TREs connecting corresponding TFs to the
respective transcripts. Interestingly, many of the genes
identified by SSH are transcription factors which emphasize the use of SSH to identify low expression transcripts.
Mucosa control [MC], (figure 2)
The regulatory network for the control bladder mucosa
(MC) was obtained in comparison to detrusor control and
contained the following over-represented TREs: GA-binding protein (GABP), YY1 (yin yang 1), SF-1 (steroidogenic
factor-1), EF2, CRE-BP1, and Sp-3 (trans-acting transcription factor 3).

GABP, also known as nuclear respiratory factor 2 (NRF-2),
is a transcriptional coordinator of mitochondrial and
nuclear-encoded subunits of cytochrome oxidase genes
[20]. NRF-2 responds to increased neuronal activity by
translocating from the cytoplasm to the nucleus, where it
engages in transcriptional activation of target genes [21].
GABP is abundant in the kidney [22], however, the information about GABP is scanty in the rest lower urinary
tract.

http://www.biomedcentral.com/1472-6793/6/1

serum response factor (SRF) [23]. Interestingly, in the
inflamed mucosa YY1 was not expressed and SRF was considered over-represented (Figure 2). YY1 along with GAPB
drives the expression of myosin light chain phosphatase
(mylc2b) which can be developmentally regulated in
mammalian urinary bladders [24] and it is involved in the
bladder response to obstruction [25].
SF-1 is a zinc finger motif of nuclear receptors [26] essential for steroidogenesis as well as for the development of
the reproductive axis [27]. CRE-BP1, which is an ubiquitous basic-leucine zipper, is required for normal skeletal
development.
YY1, SF-1, and EF2 were found upstream of ambladder
(RIKEN clone 9530014P05 or prothymosin alpha). Prothymosin alpha is an oxidative stress-protecting gene [28]
and transgenic mice over-expressing this transcript
develop polycystic kidney disease PKD [29]. Another gene
downstream of SF-1 was calponin 1 (cnn1). Cnn1 encodes
for a multifunctional protein whose expression is tightly
restricted to differentiated smooth muscle cell lineages
during embryonic and post-natal life [30].
SF-1 and CRE-BP1 were found upstream of sac1 (a murine
homolog of S. cerevisiae suppressor of actin mutations).
Finally, an additional TRE, Sp-3 was found upstream of
sc1 which is a calcium binging protein and an extracellular
matrix protein precursor.
Epithelial-stromal interactions in bladder development
have been extensively studied [5]. However, the present
results depicted in the MC regulatory network raises the
hypothesis that the bladder mucosa exhibits TREs and
genes whose proteins may regulate the smooth muscle
phenotype (Figure 2).
Detrusor control [DC] (figure 5)
The regulatory network for the control detrusor smooth
muscle suggests that Pax-3 plays a central role. In addition
to Pax-3, other TREs such as: PITX2, CDP, and c-Myb were
also found over-represented (figure 5).

Pax-3 was found upstream of the following transcripts:
prion protein (prnp), cathepsin L (ctsl), stromal cell
derived factor receptor 1 (sdfr1) [31], thrombospondin,
type I domain containing 6 (thsd6), and uroplakin 1b
(upk1b). Prnp seems to be involved in cell-to-cell interaction and its expression has been observed in germ cell differentiation during spermatogenesis [32]. Ctsl is a
lysosomal proteolytic enzyme and an imbalance between
ctsl and its inhibitors is believed to correlate with bladder
tumor progression [33].

YY1 is a zinc finger TF which is thought to regulate cell
growth and differentiation. YY1 normally antagonizes
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Table 4: Differential expression of selected SSH transcripts by quantitative real-time polymerase chain reaction (QRT-PCR) ***
Genes

Normalized CT values
Average (n = 3)

Cts h
Eif4ebp2
Gst m1
Gst o1
Serpina3n
Sprr 2A
Upk1a
Upk1b
Calm2
Cnn1
Smoc2
Bcap31
Catenin
Mafb
Pls3
Prss11
Syn1
Lamp2
Mpp1
Sepp1
Thsd6
IFIT3
Ifrg15
Sdfr1
Siva
Prnp

log2 CT X1000000

Fold Change (Delta CT Values)*

SEM

LD

LM

CD

CM

LD

LM

CD

CM

LD

LM

CD

CM

CD/CM

CM/CD

LD/LM

LD/CD

LM/CM

26.5
36.5
23.4
36.0
21.8
29.4
32.5
26.5
23.2
32.1
33.9
33.3
36.9
32.1
37.4
29.9
30.1
31.6
31.0
23.0
28.1
30.4
27.9
24.4
26.7
24.1

24.2
30.4
19.1
26.9
21.1
21.8
24.4
22.2
24.0
33.1
34.7
29.2
33.0
30.1
35.3
27.9
25.3
31.1
30.0
23.9
28.3
31.2
27.9
25.6
25.8
25.7

26.1
33.7
23.2
35.5
26.1
25.4
30.0
26.7
22.2
27.2
26.0
26.7
27.1
31.8
28.6
25.8
24.1
28.1
29.2
22.0
28.3
30.8
28.2
24.1
27.1
23.3

24.1
30.9
18.2
29.8
23.5
19.8
23.7
21.4
23.8
31.0
28.4
26.9
28.0
30.5
29.3
24.5
22.8
27.8
29.5
21.6
28.0
30.9
27.6
24.8
25.8
24.6

0.03
0.62
0.32
0.14
0.03
0.06
0.18
0.04
0.11
0.50
0.06
0.40
0.23
0.65
0.10
0.05
0.22
0.21
0.44
0.06
0.13
0.08
0.03
0.06
0.03
0.02

0.01
0.07
0.02
0.17
0.02
0.14
0.01
0.02
0.09
0.09
0.27
0.07
0.07
0.10
0.18
0.03
0.04
0.14
0.11
0.03
0.08
0.00
0.05
0.09
0.07
0.07

0.05
0.07
0.00
0.56
0.09
0.03
0.02
0.12
0.04
0.15
0.04
0.08
0.42
0.34
0.14
0.06
0.21
0.05
0.11
0.08
0.03
0.12
0.09
0.10
0.06
0.02

0.01
96
19
70
18
0.05 95252 1430 13833 1974
0.06
11
1
9
0
0.06 68660
125 47023 909
0.05
4
2
72
12
0.00
697
4
45
1
0.13
6162
23 1050
14
0.05
98
5
112
3
0.11
9
17
5
14
0.05
4547 9400
149 2177
0.06 15953 27402
68 352
0.01 10331
627
106 127
0.09 130085 8592
143 273
0.44
4703 1154 3615 1570
0.15 179012 41906
402 661
0.00
999
259
59
23
0.13
1148
42
18
7
0.01
3342 2379
285 230
0.19
2114 1090
632 753
0.05
8
15
4
3
0.04
293
329
338 272
0.05
1455 2396 1885 1988
0.07
254
245
307 210
0.09
23
52
18
29
0.07
110
59
147
59
0.00
18
53
11
26

3.9
7.0
29.9
51.7
6.1
51.0
76.4
39.3
0.3
0.1
0.2
0.8
0.5
2.3
0.6
2.5
2.4
1.2
0.8
1.4
1.2
0.9
1.5
0.6
2.5
0.4

0.3
0.1
0.0
0.0
0.2
0.0
0.0
0.0
3.0
14.6
5.2
1.2
1.9
0.4
1.6
0.4
0.4
0.8
1.2
0.7
0.8
1.1
0.7
1.6
0.4
2.5

5.0
66.6
19.7
550.9
1.6
185.1
271.4
20.6
0.6
0.5
0.6
16.5
15.1
4.1
4.3
3.9
27.3
1.4
1.9
0.6
0.9
0.6
1.0
0.4
1.9
0.3

1.4
6.9
1.2
1.5
0.1
15.3
5.9
0.9
2.0
30.5
234.8
97.6
912.8
1.3
444.9
17.1
65.6
11.7
3.3
2.0
0.9
0.8
0.8
1.3
0.7
1.7

1.1
0.7
1.8
0.1
0.2
4.2
1.7
1.7
1.2
4.3
77.7
4.9
31.5
0.7
63.4
11.0
5.9
10.3
1.4
4.8
1.2
1.2
1.2
1.8
1.0
2.0

*(ratio of antilog2 of cycle threshold values)
** (bolded cells indicate values greater than 3.0)
***Female C57BL/6J mice were instilled with saline (n = 20) or LPS (n = 20). Twenty four hours after LPS instillation, mice were euthanized, the
bladder was removed and placed in RNAlater™ (Ambion) for separation of the mucosa and submucosa from the detrusor smooth muscle, as
described in Material and Methods. Four sample groups were obtained as follows: control mucosa (CM), control detrusor (CD), LPS-treated
mucosa (LM), and LPS-treated detrusor (LD). The QRT-PCR amplifications were accomplished on an ABIPRISM 7700 using SYBRGreen I dye assay
chemistry
All samples were run in triplicate with the appropriate single QRT-PCR controls (no reverse transcriptase and no template). From the QRT-PCR
data, an average cycle threshold (Ct) value was calculated from the triplicate reactions. Averaged Ct values were then normalized (to adjust for
different amounts of cDNA within each reaction) to the exongenous control gene, RCA. The relative expression level of each transcript within each
sample group (CD, CM, LD, and LM) was determined by calculating the ratio of the antilog2 of the delta Ct values.

In addition to ctsl, the detrusor also presents ctsh under the
control of c-Myb. Interestingly, thsd is involved in bladder
cancer development [34] and is a target for methylation
[35]. In addition, thsd has been described as inhibitor of
angiogenesis. Finally, upk1b gene is highly expressed in
normal human urothelium and its mRNA was undetectable or markedly reduced in bladder carcinoma [36].
Interestingly, the control detrusor normally expresses
genes in the Pax-3 pathway that maintain neural progenitor cells [37] and myoblasts [38] undifferentiated. Therefore, our data suggests that Pax-3-regulated suppression of
neural development in control detrusor changed substan-

tially during inflammation and genes involved in neuronal development such as syn were found to be upregulated. The later implies that detrusor instability may
be a consequence of alterations in Pax-3 pathway leading
to increased maturation of neural progenitor cells within
the bladder smooth muscle.
Mucosa inflamed versus control [MIC]. (figure 3)
Of all regulatory networks (Figures 2, 3, 4, 5, 6, 7), MIC
was the only one presenting NF-κB (p < 0.01), (Figure 3).
These results confirmed our previous observation that it is
the bladder mucosa and in particular, the urothelium,
that responds to LPS with NF-κB translocation [39]. This
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LPS

Mouse
bladder

a)
SALINE

b)

CONTROL MUCOSA = CM

LPS MUCOSA = LM

CONTROL DETRUSOR = CD

LPS DETRUSOR = LD

TESTER

DRIVER

mRNA

mRNA

cDNA

cDNA

SSH
RNA

c)

LIBRARIES
MC
DC
MIDI
MIC
DIMI
DIC

CM-CD
CD-CM
LM-LD
LM-CM
LD-LM
LD-CD

i) target validation

h)

Unique
Clones

Processing TA
Clones

e) sequencing

f) in silico
h)

Adapters

Hybridization
and subtraction

d) screening

QRT-PCR

REGULATORY
NETWORKS

Adapters

BLAST

TF

Accession number

g)
PAINT

Annotation
Gene Ontology
Mouse Genome

Figure 1
Overall
experimental design
Overall experimental design. a) A well established animal model of LPS- induced bladder inflammation was used. b) RNA
was extracted from isolated detrusor muscle and mucosa layers. c) Extracted RNA was used to generate 6 different libraries
by suppressive subtraction hybridization (SSH) in order to determine bladder tissue- and treatment- dependent transcripts. d)
Transcripts were then screened and e) Sequenced f) All unique transcripts were fully annotated by querying public (PubMed,
Gene Ontology, Mouse Genome [108]) and private (Transfac professional [109]) databases. g) The accession number of each
SSH-selected transcript was uploaded into the PAINT 3.3 feasnet builder [110] to query the Transfac database [109]. h) A regulatory network for each library was originated by a combination of SSH-selected transcripts and over-represented TF (0 < p
< 0.05) in the matrix when compared to the PAINT database reference equivalent to the all the genes in the Ensembl annotated genome (Figures 2, 3, 4, 5, 6, 7). i) Unique clones were validated by QRT-PCR.
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to oxygen. Finally, pls3 was found by differential display
to have increased expression in cisplatin-resistant human
cancer cells [45].

MC
SP3

GABP

sc1
mylc2b
CRECRE-BP1

E2F

YY1

ambladder

SFSF-1

sac1

cnn1
Figure
Transcripts
mucosa
2when
andcompared
TREs over-represented
to control detrusor
in the(MC)
control
Transcripts and TREs over-represented in the control mucosa when compared to control detrusor
(MC). The regulatory network was determined by a combination of SSH-selected transcripts (green) and PAINT 3.3
query of transcription factor database (TRANSFAC). PAINT
3.3 was employed to examine 2000 base pairs of regulatory
region upstream of the transcriptional start site of each differentially expressed transcript detected with the SSH. Genbank accession numbers were used as the gene identifiers in
PAINT test files. Individual elements of the matrix are
colored by the significance p-values. Over-representation in
the matrix when compared to the reference (all TFs in the
PAINT database) is indicated in orange (0 < p < = 0.01) or
green (0.01 < p < 0.05). For a detailed origin of each library
please see Figure 1 and Material and methods.

independent identification of NF-κB [39], which is known
to play a key role in bladder inflammation [40] strengthens confidence in the identification of novel pathways.
Three transcripts were found downstream of NF-κB: catenin (cadherin-associated protein, delta 1), cox7b, and pIs3
(plastin 3 T-isoform). Regarding catenin, others have
described its presence in the bladder mucosa and in particular in the urothelium [41]. Indeed, alpha1-catenin was
reported to be reduced in bladder urothelial cells treated
with anti-proliferative factor [42] which make this transcript a possible target in cystitis. Moreover, p120-catenin
is frequently altered and/or lost in tumors of bladder [43].
Finally, bladder cancers harboring a beta-catenin mutation
may represent aggressive biological behavior with
enhanced proliferating activity [44]. Cox7b encodes cytochrome C oxidase, subunit VIIb which is the terminal
component of the mitochondrial respiratory chain and
catalyzes the electron transfer from reduced cytochrome C

In addition to NF-κB, MIC also had SRF that along with
several zinc finger TFs (SF-1 [Steroidogenic factor 1]; Gfi1 (growth factor independent 1); ik-3 (Ikaros 3); and vMaf
[basic region leucine zipper]), drive the activity of actg1.
Actg1 is a highly conserved protein involved in various
types of cell motility, and maintenance of the cytoskeleton.
The MIC regulatory network also includes the following
unique transcripts: smoc2 (secreted modular calciumbinding protein 2), amcq (adult male corpora quadrigemina cDNA; RIKEN clone:B230340L02), prss11 (Serine protease 11), and ifit3 (Interferon-induced protein
with tetratricopeptide repeats 3). Smoc2 is a widespread
glycoprotein with a calcium-dependent conformation
[46]. Prss11 encodes a secreted trypsin (HtrA1) that regulates the availability of insulin-like growth factors (IGFs)
by cleaving IGF-binding proteins and therefore, may function as a regulator of cell growth [47]. HtrA is involved in
stress response pathways [48]. Interestingly, down-regulation of prss11 expression may be an indicator of
melanoma progression [49].
Ifit3 was originally cloned from a cDNA library prepared
from the murine cell line, RAW 264.7, after bacterial LPS
stimulation [50]. Although it is a transcript induced by
IFN [51], its function is still unknown.
Grp58 encodes a ubiquitously expressed chaperone protein that resides in the endoplasmic reticulum and is part
of the protein folding machinery [52]. It is likely that
grp58 is involved in the oncogenic transformation[53]
since expression analysis revealed an up-regulation of
grp58 in breast, uterus, lung, and stomach tumors [54].
Together these results confirmed that the bladder mucosa
expresses unique transcripts involved in cell growth,
motility, and cytoskeleton, protein folding, and proteases.
Some of these transcripts have been described to be
altered in cystitis as well as in LPS-induced bladder
inflammation. However, the most striking result was that
of 6 different networks, the MIC library was the only one
to have over-representation of NF-κB.
Mucosa inflamed versus detrusor inflamed [MIDI], (figure
4)
The question being answered by this experiment was
whether or not the bladder mucosa sets the stage for LPSinduced inflammatory responses by up-regulating a
unique set of genes and TFs distinct from the detrusor
muscle.
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agent for the treatment of inflammation [58], diabetes
[59], and neurodegenerative diseases [57,58,60].

MIC
ELKELK-1

pls3

catenin
NFN
NFNB

CCAAT BOX

HMX3

MAJOR TT-A

smoc2
ctsl

grp58

cox7b

ctse

amcq

TCF11
SRF
SFSF-1

prss11

VMAF

actg1
GFIGFI-1

ifit3

IKIK-3

Figure 3when
Transcripts
inflamed
andcompared
TREs over-represented
to control mucosa
in the(MIC)
mucosa
Transcripts and TREs over-represented in the
mucosa inflamed when compared to control mucosa
(MIC). The regulatory network was determined by a combination of SSH-selected transcripts (green) and PAINT 3.3
query of transcription factor database (TRANSFAC). PAINT
3.3 was employed to examine 2000 base pairs of regulatory
region upstream of the transcriptional start site of each differentially expressed transcript detected with the SSH. Genbank accession numbers were used as the gene identifiers in
PAINT test files. Individual elements of the matrix are
colored by the significance p-values. Over-representation in
the matrix when compared to the reference (all TFs in the
PAINT database) is indicated in orange (0 < p < = 0.01) or
green (0.01 < p < 0.05). For a detailed origin of each library
please see Figure 1 and Material and methods.

In terms of TFs, the upstream stimulatory factor (USF) was
the most significantly over-represented (p < 0.001) and
driving unique transcripts (figure 4). USF dimerizes to regulate transcription through E-box motifs in target genes.
Although widely expressed, they can mediate tissue-specific transcripts. USF is stimulated by glucose in murine
mesangial cells, binds to TGF-β1 promoter, contributes to
TGF-β1 expression, and may play a role in diabetesrelated gene regulation in the kidney [55]. Others have
shown that USF binding activity is enhanced in response
to LPS [56].
Another interesting TF was the liver X-activated receptors
(LXR) found upstream of several transcripts bearing USF
sequence. LXR is a member of the nuclear receptor superfamily [57] is a negative regulator of macrophage inflammatory gene expression [58], and a putative therapeutic

LIM-only proteins (LMO), which consist of LMO1,
LMO2, LMO3, and LMO4, are involved in cell fate determination and differentiation during embryonic development [61]. LMO2 was originally identified through its
involvement in T-cell leukemia and subsequently shown
to be critical for normal hematopoietic and endothelial
development [61]. Accumulating evidence suggests that
LMO1 and LMO2 act as oncogenic proteins in T-cell acute
lymphoblastic leukemia, whereas LMO4 has recently
been implicated in the genesis of breast cancer[61].
MAZ (Myc-associated zinc finger protein), also known as
serum amyloid A-activating transcription factor-1 (SAF1), plays a major role in regulating transcription of several
inflammation-responsive genes, including matrix metalloproteinase-1 (81), the mouse mast cell protease
(mMCP)-6 [62], and function as growth suppressor in
fibroblasts [63]. SAF-1 transgenic mice are prone to
develop a severe form of inflammation-induced arthritis
[64]. MAZ is upstream of Aplp2 which is a key regulator
of structure and function of developing neuromuscular
synapses [65].
In terms of unique transcripts isolated from the MIDI
library, our results indicate that transcripts such as zfp364
(zinc finger protein 364, also known as rab7) and sir2 are
downstream of series of TFs including: USF, LXR, DEAF1,
MAZ, and Lmo2 complex (figure 4). Sir2 gene encodes a
member of the sirtuin family of proteins which are NADdependent histone/protein deacetylases [66]. Zfp364 is a
member of the Rab family of small G proteins, and regulates intracellular vesicle traffic to late endosomes [67].
Another unique transcript was the androgen-regulated
tmprss2 protease [68] known to be expressed in urogenital
tissues [69]. Tmprss2 has gained interest owing to its
highly localized expression in the prostate and its overexpression in neoplastic prostate epithelium. Once activated, the serine protease domain of tmprss2 is released
from the cell surface into the extracellular space and activates PAR (protease-activated receptor)-2 that has a role in
prostate cancer and tumor metastasis [70]. Among the
proteins correlating with cytoskeleton dynamics, our SSH
identified a transcript (wdr1) encoding a 67-kDa WD40
repeat protein 1 which is the vertebrate homologue of
actin-interacting protein 1 [71]. Wdr1 is involved in actin
dynamics and seems to be required to induce cell morphologic changes, especially mitotic cell rounding [72].
Others have shown that wdr1 was found upregulated in
the lung [73] and cell lines [74] following exposure to
nickel oxide-induced carinogenesis. Finally, MIDI library
also contained a RIKEN cDNA 2310015N07 gene that was
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Figure 4when
Transcripts
inflamed
andcompared
TREs over-represented
to detrusor inflamed
in the mucosa
(MIDI)
Transcripts and TREs over-represented in the
mucosa inflamed when compared to detrusor
inflamed (MIDI). The regulatory network was determined
by a combination of SSH-selected transcripts (green) and
PAINT 3.3 query of transcription factor database (TRANSFAC). PAINT 3.3 was employed to examine 2000 base pairs
of regulatory region upstream of the transcriptional start site
of each differentially expressed transcript detected with the
SSH. Genbank accession numbers were used as the gene
identifiers in PAINT test files. Individual elements of the
matrix are colored by the significance p-values. Over-representation in the matrix when compared to the reference (all
TFs in the PAINT database) is indicated in orange (0 < p < =
0.01) or green (0.01<p < 0.05).

described to be isolated from developing mouse libraries
but no function yet has been attributed [75].
Interestingly, a comparison between MIDI and DIMI
libraries indicates that both share LXR as a TRE. The major
difference between these two libraries was found downstream LXR activation. In the inflamed mucosa, LXR preferentially activates zfp364 and tmprrs2 whereas in the
inflamed detrusor LXR was found as a co-modulator of
actg2.
In conclusion, the mucosa regulatory network presents
USF in a central position raising the hypothesis that USFtarget promoters such as the TGF-β1 promoter are
involved in the mucosal response to inflammation and
whether mucosa inflammation follows similar diabetesrelated mucosal gene expression.
Detrusor inflamed versus detrusor control [DIC], (figure 6)
The regulatory network of the detrusor muscle, inflamed
versus control, selected the following transcripts: syn1

(Synapsin I or ribosomal protein S15a), siva (CD27-binding protein), and eif4ebp2 (negative regulation of translational initiation), (figure 6).
Syn1 is a member of the synapsin gene family which is a
neuron-specific phosphoprotein of small synaptic vesicles.Syn1 has been mapped to an evolutionarily conserved
linkage group composed of: araf1, syn1, timp, and properdin located at human chromosome Xp11.2 [76] and
mouse chromosome X [77]. Of interest, araf1 is a protooncogene which is predominantly expressed in mouse
urogenital tissues [77]. In contrast, siva has an important
role in the apoptotic pathway induced by the CD27 antigen. Others have described that siva is a direct transcriptional target for both tumor suppressors, p53 and E2F1
[78]. Finally, the eukaryotic initiation factor eIF4E and
eIF4E-binding proteins (4E-BPs) control the initiation of
protein synthesis and are part of a translational signaling
pathway sensitive to insulin [79] and rapamycin [80].
Changes in the state of phosphorylation of eIF4E and 4EBPs occur at an early stage of apoptosis [81]. Interestingly,
eIF4E selectively enhances the translation of powerful
angiogenic factors such as FGF-2 and VEGF [82] and
therefore may have a role in oncogenesis [82] as well as
inflammation.
Over represented TFs in DIC regulatory network were
NRSF (Kruppel-type zinc-finger transcriptional repressor
RE1-silencing transcription factor [REST]; also known as
the neuron-restrictive silencing factor), CREB/CRE-BP1,
E2F-1, and Evi-1.
CREB/CRE-BP1, also called transcription factor ATF-2,
binds to the cAMP response element and its activity is
enhanced after phosphorylation by stress-activated protein kinases such as c-Jun N-terminal kinase and p38. ATF2 plays a central role in TGFβ signaling by acting as a common nuclear target of both Smad and TAK1 pathways
[83].
Nrf-1 (nuclear respiratory factor 1) regulates expression of
nuclear-encoded mitochondrial genes and it was shown
to be part of the response to LPS in rats [84].
FOXp3 belongs to the forkhead gene family which comprises a diverse group of "winged-helix" TFs with important roles in development, metabolism, cancer and aging
[85]. Recently, several forkhead genes have been demonstrated to play critical roles in lymphocyte development
and effector function [85]. FoxP3 is a potential target for
treatment of experimental chronic inflammatory renal
disease [86] and type I diabetes [87]. In addition, both
FOXp3 and NRSF seems to be downstream of Wnt-Frizzled signaling [88] which was recently proposed to participate in the pathogenesis of interstitial cystitis [89].
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ATF3 represents a novel mechanism in which anti-inflammatory drugs exert their anti-invasive activity [97].
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Figure
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in the control detruTranscripts and TREs over-represented in the control detrusor when compared to control mucosa
(DC). The regulatory network was determined by a combination of SSH-selected transcripts (green) and PAINT 3.3
query of transcription factor database (TRANSFAC). PAINT
3.3 was employed to examine 2000 base pairs of regulatory
region upstream of the transcriptional start site of each differentially expressed transcript detected with the SSH. Genbank accession numbers were used as the gene identifiers in
PAINT test files. Individual elements of the matrix are
colored by the significance p-values. Over-representation in
the matrix when compared to the reference (all TFs in the
PAINT database) is indicated in orange (0 < p < = 0.01) or
green (0.01 < p < 0.05). For a detailed origin of each library
please see Figure 1 and Material and methods.

E2F, E2F-1, and Rb-E2F-1 belong to a family of TFs implicated in the regulation of cell proliferation and their binding sites are present in the promoters of several growthregulating genes. E2F family members are functionally
regulated, in part, by complex formation with one or
more members of the nuclear pocket protein family such
as the retinoblastoma protein (Rb) and play a role in neuronal development [90] by acting as negative regulator of
cell proliferation. The interplay between Rb and E2F is
critical for proper cell cycle progression [91]. Of interest,
E2F-1 has a growth-promoting effect in bladder superficial TCC [92].
ATF-3 (activating transcription factor 3) is transcriptional
repressor involved in survival and regeneration of sensory
neurons [93,94] that responds to insulin [95]. ATF3 is also
a novel stress-activated regulator of p53 protein stability/
function providing the cell with a means of responding to
a wide range of environmental insults [96]. In addition,

The proposed role of nrsf/rest is that of a transcriptional
silencer that restricts neuronal gene expression to the
nervous system by silencing their expression in non-neural tissues [98]. Interestingly, loss of nrst function in
human prostate carcinoma cells is associated with neuroendocrine phenotype, tumor progression, and androgen independence [99]. Others investigators indicated
that nrst also modulates the cholinergic gene locus
[100,101] which may have some implication in detrusor
instability. Recently, it was proposed that activation of the
rest/nrsf target genes overrides muscle differentiation pathways and converted myoblasts to a physiologically active
neuronal phenotype [102]. It remains to be determined
whether nrst promotes the same transformation in the
inflamed detrusor muscle. The latter would explain the
hyperactivity of detrusor muscle observed in over-active
bladder disorders such as obstruction, incontinence, and
inflammation.
In conclusion two major networks are proposed to be
active in the detrusor inflamed when compared to control. One containing a neuron-specific phosphoprotein of
small synaptic vesicles (syn) and the other an important
protein of apoptotic pathway (siva). In both cases, analysis of the intense upstream promoter network leads us to
the hypothesis that both genes represent a common
downstream target of several pro-inflammatory stimuli.
Detrusor inflamed versus mucosa inflamed [DIMI], (figure
7)
The question being answered by this experiment was
whether or not the inflamed detrusor muscle expresses
unique transcripts and TFs distinct from the bladder
mucosa.

Two major pathways could be constructed with the combination of SSH and PAINT results. The first involves key
smooth muscle proteins, a myosin light chain encoded by
my19 and gamma actin encoded by actg2. Gamma actins
are highly conserved proteins that are involved in various
types of cell motility, and maintenance of the cytoskeleton. In addition, a role for smooth muscle alpha actin in
force generation by the urinary bladder has been suggested [103]. Several TREs upstream of actg 2 and my19
were over-represented in MIDI, including LXR which was
described above, SRF, COUP, Pax-9, CP2, and RFX1.
A second pathway involved the transcripts elp3, gus, and
ddx3 and two TFs COMP1 and IRF. Ddx3 is a putative RNA
helicase and a member of a highly conserved DEAD box
subclass. RNA helicases are highly conserved enzymes
involved in transcription, splicing, and translation [104].
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Transcripts and TREs over-represented in the detrusor inflamed when compared to detrusor control
(DIC). The regulatory network was determined by a combination of SSH-selected transcripts (green) and PAINT 3.3
query of transcription factor database (TRANSFAC). PAINT
3.3 was employed to examine 2000 base pairs of regulatory
region upstream of the transcriptional start site of each differentially expressed transcript detected with the SSH. Genbank accession numbers were used as the gene identifiers in
PAINT test files. Individual elements of the matrix are
colored by the significance p-values. Over-representation in
the matrix when compared to the reference (all TFs in the
PAINT database) is indicated in orange (0 < p < = 0.01) or
green (0.01 < p < 0.05). For a detailed origin of each library
please see Figure 1 and Material and methods.

There are several examples of the involvement of RNA helicases in differentiation of germ cells, particularly in spermatogenesis. Upstream of ddx3, PAINT selected a TF that
cooperates with myogenic proteins (COMP1) and Interferon Regulatory Factor (IRF). Transcription of IRF is synergistically activated by products of inflammation such as
IFNγ and TNFα [105].
Two other transcripts were found downstream of COMP1:
Gus (beta-glucoronidase) and elp3. Gus is a sensitive indicator LPS activation of macrophages. Elp3 is one of the sub
units of the elongator complex, an acetyltransferase
important for normal histone acetylation involved in
elongation of RNA polymerase II transcription.
By comparing the inflamed detrusor and mucosa (DIMI),
the fundamental difference observed was the up-regulation in the detrusor of genes and TFs related to smooth
muscle function. It is fair to propose that this network
could underlie detrusor instability during inflammation.

We here present a novel approach to understanding the
bladder response to inflammation as a system. By using
SSH, low abundance, differentially expressed transcripts
could be detected that probably would have been lost in
the background "noise" of a microarray study. That these
genes were, in fact, key players was shown by the remarkable concordance in the transcriptional regulatory elements identified and by target validation with QRT-PCR.
We suggest that the results identified key players governing the normal growth and differentiation of bladder
mucosa and urothelium as well as the cross-communication of these layers during inflammation resulting from a
number of pathologic processes.
As genes encoding DNA-binding TFs are the largest class
of genes involved in human oncogenesis, it was obvious
that in several instances the vast amount of information
was related to cancer, in general and to bladder carcinoma, in particular. Interestingly, some of the TFs and
their correlated downstream transcripts originally
described to be involved in organogenesis were also activated during inflammation. The implications of these
findings may represent one more link between inflammation and cancer.
The networks here described could well represent key targets for development of novel drugs for treatment of bladder diseases.

Methods
Animals
Ten to twelve-week old female C57BL/6J mice were used
in these experiments that were performed in conformity
with the "Guiding Principles for Research Involving Animals and Human Beings (OUHSC Animal Care & Use
Committee protocol #002-109).
Induction of inflammation
Acute inflammation was induced by instillation of LPS
into the mouse bladder, as described previously [8,9,106].
Female mice were anesthetized (ketamine 200 mg/kg and
xylazine 2.5 mg/kg, i.p.), then transurethrally catheterized
(24 Ga.; 3/4 in; Angiocath, Becton Dickson, Sandy, Utah),
and the urine was drained by applying slight digital pressure to the lower abdomen. Because the bladder of 10week old mice has an average capacity of 250 µl, the urinary bladders were instilled with 200 µl of one of the following substances: pyrogen-free saline (control) or
Escherichia coli LPS strain 055:B5 (Sigma, St. Louis, MO;
100 µg/ml),) (figure 1a). Substances were infused at a
slow rate to avoid trauma and vesicoureteral reflux. To
ensure consistent contact of substances with the bladder,
infusion was repeated twice within a 1-hour interval and
a 1-ml syringe was maintained in the catheter end during
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Transcripts and TREs over-represented in the detrusor inflamed when compared to mucosa inflamed
(DIMI). The regulatory network was determined by a combination of SSH-selected transcripts (green) and PAINT 3.3
query of transcription factor database (TRANSFAC). PAINT
3.3 was employed to examine 2000 base pairs of regulatory
region upstream of the transcriptional start site of each differentially expressed transcript detected with the SSH. Genbank accession numbers were used as the gene identifiers in
PAINT test files. Individual elements of the matrix are
colored by the significance p-values. Over-representation in
the matrix when compared to the reference (all TFs in the
PAINT database) is indicated in orange (0 < p < = 0.01) or
green (0.01 < p < 0.05). For a detailed origin of each library
please see Figure 1 and Material and methods.

this period. The catheter was removed, and mice were
allowed to void normally. Twenty-four hours after instillation, mice were euthanized with pentobarbital (100 mg/
kg, i.p.) and bladders were removed rapidly.
Tissue layers – separating the mucosa from detrusor
Immediately after removal from the animal, bladders
were placed in RNAlater™ (Ambion) and visualized under
a dissecting microscope (Nikon SMZ 1500). The detrusor
smooth muscle was separated by blunt dissection away
from the mucosa which contained the epithelium and
sub-epithelial layers, (see Additional file 1).
Suppression subtractive hybridization (SSH) (9)
A total of six libraries were obtained by SSH (figure 1c). In
order to standardize the names of the groups and to correlate with delta CT values (see below), the SSH libraries
were named after the tester minus driver. The first library
(MC) was obtained by using the mucosa removed from
control saline-treated mice (CM) as tester and the respective detrusor smooth muscle (CD) as driver. The resultant

subtraction MC was supposed to contain genes preferentially expressed in the control mucosa. The second library
was the reverse of MC and therefore, CD was used as tester
and CM as driver and will contain genes preferentially
expressed in the detrusor smooth muscle of control mice
(DC). The other 4 libraries were obtained to investigate
genes whose expression was altered during LPS-induced
inflammation (figure 1c). The samples used for each SSH
were obtained by pooling RNA from 20 individual mice.
The pooling was necessary in order to obtain enough RNA
from each layer without amplification.
Construction of subtractive cDNA libraries
mRNA was isolated from total RNA using Poly(A) Quick
mRNA Isolation Kit (Stratagene, La Jolla, CA) according to
the manufacture's protocol. To compare the two populations of resulting cDNA the method of SSH was performed using PCR-Select cDNA Subtraction Kit (BD
Biosciences – Clontech, Palo Alto, CA), as described by
Diatchenko and colleagues [18]. This method selectively
amplifies differentially expressed sequences, and the generation of high- and low-abundance sequences is equalized during the first hybridization. The PCR allows
amplification of equalized differentially expressed
sequences. Each step of the cDNA synthesis and subtractive hybridization procedure was monitored using the
positive control samples provided by the manufacturer.
We verified the efficiency of subtraction by PCR analysis
by comparing GAPDH levels in subtracted and un-subtracted cDNA using the method and GAPDH primers provided by the manufacturer. For analysis of efficiency,
please see Additional file 2. For analysis of ligation, please
see Additional file 3. For the analysis of PCR products,
please see Additional file 4. For PCR analysis and subtraction efficiency, please see Additional file 5.

Next, cDNAs from the testers and drivers were digested
with RsaI. To select tissue- and treatment-specific transcripts, PCR adapters were ligated to the tester pool population. The tester cDNA pool was then hybridized with
excess cDNAs from the driver pool. After hybridization
suppression, PCR using primers specific for the tester PCR
adapters selectively amplified differentially expressed
transcripts.
Screening the clones (plating out, growing up and
analyzing the PCR clones), (figure 1d)
After the PCR subtraction, the amplification products
were cloned into the pCR 2.1 plasmid of the TA cloning
kit (Invitrogen). Ligated DNA was transformed by heat
shock in 100 µl of INVαF competent E. coli cells. Colonies
were grown overnight at 37°C on Luria broth agar plates
containing ampicillin, X-gal, and isopropyl-B-D-thiogalactopyranoside for blue/white colony selection. White
colonies were isolated and grown individually in 2 ml of
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LB medium containing ampicillin for 16 h. After plasmid
DNA isolation (Wizard® Plus SV Minipreps DNA Purification System – Promega), digestion was performed using
Xba I and BamH I, and the products analyzed in 1% agarose gels. Positive clones (representing fragments larger
than the original polylinker in the cloning vector) were
sent to a sequencing service (figure 1e), and sequences
were submitted for a BLAST analysis in GenBank for identification and annotation was done by searching the gene
ontology[16], figure 1f.
Tissue- and treatment-specific transcription factors
After annotation, a bioinformatics approach to identify
functionally relevant putative transcriptional regulatory
elements (TREs) for all SSH-selected transcripts was used
(figure 1g). We used the Promoter Analysis and Interaction Network Toolset [PAINT [13]], available online
[107], to integrate functional genomics information from
SSH-derived gene expression data with the genomic
sequence and TRE data to derive hypotheses about relevant transcriptional regulatory networks. PAINT uses the
TRANSFAC® database [14] of transcription factors and
position weight matrix descriptions of cis-acting
sequences and an associated pattern matching tool
MATCH [15] to identify statistically over-represented regulatory sites in 5' upstream sequences of related genes.
This information provides a substantially pruned list of
TFs regulating tissue- and treatment-specific genes that
were identified by SSH. Briefly, the accession numbers of
all the SSH-selected transcripts were used as an input gene
list in PAINT. Up to 2000 base pairs of 5' upstream
sequences were analyzed for the presence of TREs using a
MATCH/TRANSFAC setting to minimize false positives
and filtering the results further in PAINT to consider only
those hits with 100% match to the 5 bp core TRE
sequence. The interaction matrix contained 79 genes and
162 TREs.

PAINT can analyze the interaction matrix for over-represented TREs in subsets/clusters of related genes, typically
grouped based on gene expression data. The library for
each transcript (MC, DC, MI, MIDI, DI and DIMI) was
considered as the cluster label and provided as the GeneCluster information in the PAINT analysis and visualization step. The TRE over-representation in PAINT is calculated as the hyper-geometric probability of the observed
number of TREs in a given cluster as compared to that in
randomly selected gene clusters from a 'reference' list. In
this study, all the genes in the genome as annotated in
Ensembl were used to construct the interaction matrix for
use as the reference. To construct the hypothesized regulatory networks, TFs were chosen based on the probability
of over-representation (p < 0.05) in any of the six gene
groups as compared to all the genes in the genome (or
equivalently in PAINT promoter database).

http://www.biomedcentral.com/1472-6793/6/1

Target validation by QRT-PCR (figure 1i)
RNA isolation and cDNA synthesis
An additional 40 C57BL/6J female mice, ten to twelveweeks old underwent the same intravesical treatment as
described above [LPS, (n = 20 mice) and saline (n = 20
mice)]. Twenty four hours after LPS instillation, mice were
euthanized, the bladder was removed and placed in
RNAlater™ (Ambion) for separation of the mucosa and
submucosa from the detrusor smooth muscle, as
described above. Four sample groups were obtained as
follows: control mucosa (CM), control detrusor (CD),
LPS-treated mucosa (LM), and LPS-treated detrusor (LD).
Bladders were pooled and homogenized in Ultraspec RNA
solution (Biotecx Laboratories, Houston, TX) for isolation
and purification of total RNA used for QRT-PCR. High
RNA quality from each of these four groups was verified
by capillary gel electrophoresis using an Agilent 2100 Bioanalyzer (Agilent Technologies, Inc, Palo Alto, CA). RNA
concentration was determined by spectrophotometry
using a NanoDrop® ND-1000 UV-Vis Spectrophotometer
(Nano Drop Technologies, Wilmington, DE). Subsequently, this total RNA was used as a template for each of
the first-strand cDNA syntheses. Prior to cDNA synthesis,
an exogenous standard of A. thaliana (RCA) mRNA (Stratagene, L Jolla, CA, USA) was added (0.1 ng) to each CM,
CD, LM, and LD total RNA (2 µg) sample for normalization of succeeding gene expression data. RNA was reversetranscribed according to the Omniscript RT™ kit (Qiagen,
Valencia, CA) instructions and subsequently purified
using the Montage PCR 96-well cleanup plate (Millipore,
Billerica, MA). Prior to the PCR, primer pairs were
designed utilizing both Primer Express® (ABI, Foster City,
CA) and NetPrimer (PREMIER Biosoft International, Palo
Alto, CA) software. Primers were designed according to
the general guidelines outlined in the Primer Express®
User Bulletin. Details of the primers and the Genebank
accession numbers are given in Table 1. The designed
primers shared 100% homology with the target sequence
but no significant homology with other sequences.

The QRT-PCR amplifications were accomplished on an
ABI®PRISM 7700 using SYBR®Green I dye assay chemistry.
A 15 µL PCR assay for each gene of interest consisted of
7.5 µL of 2X SYBR®Green PCR mix (Applied Biosystems
Inc., Foster City, CA), 4.9 µl of H20, 0.6 µl (30 pmoles) of
gene-specific forward and reverse primers, and 2 µl (1 ng)
of cDNA template. All samples were run in triplicate with
the appropriate single QRT-PCR controls (no reverse transcriptase and no template). Cycling conditions used for all
amplifications were one cycle of 95°C for 10 minutes and
40 cycles of 95°C for 15 seconds and 60°C for 1 minute.
Following the QRT-PCR, dissociation curve analysis was
performed to confirm the desired single gene product.
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From the QRT-PCR data, an average cycle threshold (Ct)
value was calculated from the triplicate reactions. Averaged Ct values were then normalized (to adjust for different amounts of cDNA within each reaction) to the
exongenous control gene, RCA. The relative expression
level of each transcript within each sample group (CD,
CM, LD, and LM) was determined by calculating the ratio
of the antilog2 of the delta Ct values. The resultant foldchange data is presented in Table 4.
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